• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行对急性冠状动脉综合征住院治疗的影响:一项多国研究。

Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study.

机构信息

Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, México.

Department of Cardiology, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

出版信息

QJM. 2021 Nov 13;114(9):642-647. doi: 10.1093/qjmed/hcab013.

DOI:10.1093/qjmed/hcab013
PMID:33486512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7928691/
Abstract

BACKGROUND

COVID-19 has challenged the health system organization requiring a fast reorganization of diagnostic/therapeutic pathways for patients affected by time-dependent diseases such as acute coronary syndromes (ACS).

AIM

To describe ACS hospitalizations, management, and complication rate before and after the COVID-19 pandemic was declared.

DESIGN

Ecological retrospective study. Methods: We analyzed aggregated epidemiological data of all patients > 18 years old admitted for ACS in twenty-nine hub cardiac centers from 17 Countries across 4 continents, from December 1st, 2019 to April 15th, 2020. Data from December 2018 to April 2019 were used as historical period.

RESULTS

A significant overall trend for reduction in the weekly number of ACS hospitalizations was observed (20.2%; 95% confidence interval CI [1.6, 35.4] P = 0.04). The incidence rate reached a 54% reduction during the second week of April (incidence rate ratio: 0.46, 95% CI [0.36, 0.58]) and was also significant when compared to the same months in 2019 (March and April, respectively IRR: 0.56, 95%CI [0.48, 0.67]; IRR: 0.43, 95%CI [0.32, 0.58] p < 0.001). A significant increase in door-to-balloon, door-to-needle, and total ischemic time (p <0.04 for all) in STEMI patents were reported during pandemic period. Finally, the proportion of patients with mechanical complications was higher (1.98% vs. 0.98%; P = 0.006) whereas GRACE risk score was not different.

CONCLUSIONS

Our results confirm that COVID-19 pandemic was associated with a significant decrease in ACS hospitalizations rate, an increase in total ischemic time and a higher rate of mechanical complications on a international scale.

摘要

背景

COVID-19 对医疗系统组织提出了挑战,需要快速调整诊断/治疗途径,以治疗急性冠状动脉综合征(ACS)等时间依赖性疾病的患者。

目的

描述 COVID-19 大流行宣布前后 ACS 住院、管理和并发症发生率。

设计

生态回顾性研究。方法:我们分析了来自四大洲 17 个国家的 29 个心脏中心的所有年龄大于 18 岁的 ACS 住院患者的聚合流行病学数据,时间跨度为 2019 年 12 月 1 日至 2020 年 4 月 15 日。2018 年 12 月至 2019 年 4 月的数据用作历史对照期。

结果

ACS 住院患者每周数量呈显著下降趋势(20.2%;95%置信区间 [1.6,35.4],P=0.04)。4 月第二周的发病率下降了 54%(发病率比:0.46,95%CI [0.36,0.58]),与 2019 年同期相比也有显著差异(分别为 3 月和 4 月,发病率比:0.56,95%CI [0.48,0.67];0.43,95%CI [0.32,0.58],p<0.001)。在大流行期间,报告了 STEMI 患者的门球时间、门针时间和总缺血时间显著增加(所有 P<0.04)。最后,机械并发症患者的比例更高(1.98% vs. 0.98%;P=0.006),而 GRACE 风险评分无差异。

结论

我们的研究结果证实,COVID-19 大流行与 ACS 住院率显著下降、总缺血时间增加以及国际范围内机械并发症发生率升高有关。

相似文献

1
Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study.COVID-19 大流行对急性冠状动脉综合征住院治疗的影响:一项多国研究。
QJM. 2021 Nov 13;114(9):642-647. doi: 10.1093/qjmed/hcab013.
2
"Missing" acute coronary syndrome hospitalizations during the COVID-19 era in Greece: Medical care avoidance combined with a true reduction in incidence?新冠疫情时期希腊“缺失”的急性冠脉综合征住院患者:是医疗规避还是发病率的真实下降?
Clin Cardiol. 2020 Oct;43(10):1142-1149. doi: 10.1002/clc.23424. Epub 2020 Jul 21.
3
Reduced rate of admissions for acute coronary syndromes during the COVID-19 pandemic: an observational analysis from a tertiary hospital in Germany.新冠疫情期间急性冠脉综合征入院率降低:来自德国一家三级医院的观察性分析
Herz. 2020 Nov;45(7):663-667. doi: 10.1007/s00059-020-04991-3. Epub 2020 Oct 7.
4
Impact of the COVID-19 pandemic on acute coronary syndromes.COVID-19 大流行对急性冠状动脉综合征的影响。
Swiss Med Wkly. 2020 Dec 31;150:w20448. doi: 10.4414/smw.2020.20448. eCollection 2020 Dec 14.
5
Impact of the COVID-19 pandemic on coronary invasive procedures at two Italian high-volume referral centers.COVID-19 大流行对两家意大利高容量转诊中心的冠状动脉介入治疗的影响。
J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):869-873. doi: 10.2459/JCM.0000000000001101.
6
Incidence of acute coronary syndrome during national lock-down: Insights from nationwide data during the Coronavirus disease 2019 (COVID-19) pandemic.国家封锁期间急性冠状动脉综合征的发生率:COVID-19 大流行期间全国范围内数据的见解。
Am Heart J. 2021 Feb;232:146-153. doi: 10.1016/j.ahj.2020.11.004. Epub 2020 Nov 6.
7
Cases of acute coronary syndrome and presumed cardiac death prior to arrival at an urban tertiary care hospital in Pakistan during the COVID-19 pandemic.在巴基斯坦 COVID-19 大流行期间,到达城市三级护理医院之前出现急性冠状动脉综合征和疑似心源性死亡的病例。
PLoS One. 2022 Feb 3;17(2):e0263607. doi: 10.1371/journal.pone.0263607. eCollection 2022.
8
The National Response to Patients with Acute Coronary Syndrome during the First Wave of the COVID-19 Pandemic in Portugal.葡萄牙在 COVID-19 大流行第一波期间对急性冠状动脉综合征患者的国家应对措施。
Acta Med Port. 2022 Dec 2;35(12):891-898. doi: 10.20344/amp.18610. Epub 2022 Oct 19.
9
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic.新冠疫情期间应激性心肌病的发病率。
JAMA Netw Open. 2020 Jul 1;3(7):e2014780. doi: 10.1001/jamanetworkopen.2020.14780.
10
Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic.新冠疫情期间急性冠状动脉综合征(ACS)的管理策略和结果。
BMC Cardiovasc Disord. 2022 May 25;22(1):242. doi: 10.1186/s12872-022-02680-z.

引用本文的文献

1
Cardiac Surgery During and After the Pandemic: A Retrospective Analysis of UK Trends and Outcomes.疫情期间及之后的心脏手术:英国趋势与结果的回顾性分析
Eur J Cardiothorac Surg. 2025 Aug 2;67(8). doi: 10.1093/ejcts/ezaf246.
2
Impact of the COVID-19 pandemic on time to treatment, treatment patterns and outcomes among patients with acute coronary syndrome in Yogyakarta, Indonesia: a retrospective cohort study.印尼日惹雅加达急性冠状动脉综合征患者 COVID-19 大流行对治疗时间、治疗模式和结局的影响:一项回顾性队列研究。
BMJ Open. 2024 Oct 14;14(10):e079060. doi: 10.1136/bmjopen-2023-079060.
3
Distinct Features of Vascular Diseases in COVID-19.新冠病毒病中血管疾病的独特特征
J Inflamm Res. 2023 Jul 6;16:2783-2800. doi: 10.2147/JIR.S417691. eCollection 2023.
4
Impact of COVID-19 on Acute Myocardial Infarction Care.COVID-19 对急性心肌梗死治疗的影响。
Heart Fail Clin. 2023 Apr;19(2):221-229. doi: 10.1016/j.hfc.2022.08.004.
5
Impact of COVID-19 on Acute Myocardial Infarction Care.COVID-19 对急性心肌梗死治疗的影响。
Cardiol Clin. 2022 Aug;40(3):345-353. doi: 10.1016/j.ccl.2022.03.004. Epub 2022 Mar 23.
6
The Impact of the COVID-19 Pandemic on Hospital Services for Patients with Cardiac Diseases: A Scoping Review.COVID-19 大流行对心脏病患者医院服务的影响:范围综述。
Int J Environ Res Public Health. 2022 Mar 8;19(6):3172. doi: 10.3390/ijerph19063172.
7
Impact of the COVID-19 Pandemic on Patients With Acute Coronary Syndrome: A Tertiary Center Experience With Primary Percutaneous Intervention and Early Invasive Strategy.2019年冠状病毒病大流行对急性冠状动脉综合征患者的影响:三级中心在直接经皮冠状动脉介入治疗和早期侵入性策略方面的经验
Cureus. 2021 Dec 27;13(12):e20747. doi: 10.7759/cureus.20747. eCollection 2021 Dec.
8
2021 Update for the Diagnosis and Management of Acute Coronary Syndromes for the Perioperative Clinician.2021 年围手术期临床医生急性冠状动脉综合征诊断和管理更新。
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2767-2779. doi: 10.1053/j.jvca.2021.07.032. Epub 2021 Jul 22.